The global 3D cell culture market is growing at 15.5% CAGR owing to the increasing emphasis on developing alternatives to animal testing, rising emphasis on personalized medicine, increasing prevalence of chronic diseases, and increased funding for research. Nevertheless, the innovation of microfluid-based 3D cell cultures and emerging economies are anticipated to create promising opportunities for key players in the market.

The COVID-19 outbreak is facing challenges in the 3D cell culture market owing to the non-availability of demand and supply of 3D cell cultures. However, the rising research practices to develop novel therapies to combat COVID-19 will create opportunities for the industry players to grow in the 3D cell culture market. Using a matrix related to 3D cell culture and air-liquid interface culture, researchers working on COVID19 have investigated the mechanism of systemic effects of cell culture in vitro and have potential in physiological microenvironments. This is the main reason why 3D cell culture is used in COVID 19 studies.

Request to get a free sample copy at https://www.vynzresearch.com/healthcare/3d-cell-culture-market/request-sample

Based on application, the cancer & stem cell research segment is anticipated to have a high CAGR owing to the rising incidences of cancer and increased funding for cancer research will propel the growth of the segment. Moreover, advantages offered by 3D cell culture in cancer research such as ease of altering cell proliferation and morphology, providing realistic drug response, taking phenotypic heterogeneity, approving experimental manipulation in gene expression & cell behavior, and represent the tumor microenvironment.

North America dominates the 3D cell culture market owing to the presence of pharmaceutical and biotech companies that adopts 3D culture technology in partnership with research institutes and clinical laboratories for evolving regenerative medicines and drug discovery & development. In addition, the increasing demand for organ transplantation and expansion in R&D activities to develop technologically advanced solutions will propel the growth of 3D cell culture practices in the region.

Corning, Inc. has innovated the CorningX SERIES Cell Processing Platform for Cell and Gene Therapy Applications. This platform provides sterile, fast, efficient, and automated processing. The company also introduced the Corning Matrigel matrix 3D plate which is a more convenient, consistent, ready-to-use cell culture option to support organoid and spheroid culture models.

The prominent players in the 3D cell culture industry include Thermo Fisher Scientific Inc., Corning Incorporated, Merck & Co., Inc., Lonza Group, Reprocell, 3D Biotek, Emulate, Global Cell Solutions, Hamilton, and Insphero.

Source: VynZ Research